Pharmafile Logo

Glaucoma in perspective

- PMLiVE

AstraZeneca launches delivery service for Nexium

Expands its US direct-to-patient programme

- PMLiVE

Let’s rock the system

Marketing is about influencing the decisions your audiences make. But to get there, you may need to change your habits of a lifetime

- PMLiVE

GSK withdraws melanoma combo in EU

EMA says it needs more data to review Mekinist and Tafinlar

Novartis building

More bad news for Novartis on heart failure candidate

FDA reviewers recommend against approving serelaxin

- PMLiVE

Pfizer says Xalkori tops chemo as first line therapy

Superior progression free survival for lung cancer patients

- PMLiVE

M3 recruits Google’s former industry head of healthcare

Jenny Cowderoy joins online group's newly-expanded European operations

Novartis day

Novartis’ German poster campaign to raise vaccination awareness

In-house designed work aims to educate public about meningococcal bacteria

- PMLiVE

Running medical meetings

Learning from large-scale events

- PMLiVE

NICE refuses to back Zaltrap as Sanofi exhausts its options

Patient access scheme and appeal fail to overcome cost concerns

Otsuka’s Samsca heads clutch of Japanese approvals

Astellas' Xtandi, AstraZeneca's Forxiga and Takeda's Zacras also given the green light

- PMLiVE

Selfie campaign boosts cancer funds

Raises more than £8m for cancer charities

- PMLiVE

Gilead taken to task over Sovaldi pricing

US politicians question high cost of new hepatitis C drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links